InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the full record of transactions filed by Cochran John, Director. Director active across 2 companies, notably Aquestive Therapeutics, Inc.. Aggregated, 2 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €132k. Activity tracked since 10 May 2021. The latest transaction was disclosed on 24 July 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Cochran John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
7,643.117 shares@ US$19.63100.0% of flowLimited Liability Company UnitsSEC:0001628280-26-050148:0
Canonical exit: 22 Oct 2026 (T+90)
37,500 shares0Common StockSEC:0001214659-21-006162:0
2 of 2 declarations
About Cochran John
John Cochran is a Director at Aquestive Therapeutics, Inc. In this role, he participates in the governance and strategy of the company. Aquestive Therapeutics, Inc. is a biopharmaceutical company specializing in developing innovative treatments. John Cochran brings his expertise in the health sector to help guide strategic decisions.
